JP2008506357A5 - - Google Patents

Download PDF

Info

Publication number
JP2008506357A5
JP2008506357A5 JP2007505491A JP2007505491A JP2008506357A5 JP 2008506357 A5 JP2008506357 A5 JP 2008506357A5 JP 2007505491 A JP2007505491 A JP 2007505491A JP 2007505491 A JP2007505491 A JP 2007505491A JP 2008506357 A5 JP2008506357 A5 JP 2008506357A5
Authority
JP
Japan
Prior art keywords
env
seq
protein
env protein
fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007505491A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008506357A (ja
JP5060284B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/003339 external-priority patent/WO2005095442A1/en
Publication of JP2008506357A publication Critical patent/JP2008506357A/ja
Publication of JP2008506357A5 publication Critical patent/JP2008506357A5/ja
Application granted granted Critical
Publication of JP5060284B2 publication Critical patent/JP5060284B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007505491A 2004-03-30 2005-03-30 ウイルスタンパク質の免疫抑制作用のモデュレーションに関与するポリペプチド配列 Expired - Fee Related JP5060284B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290838.4 2004-03-30
EP04290838 2004-03-30
PCT/EP2005/003339 WO2005095442A1 (en) 2004-03-30 2005-03-30 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins

Publications (3)

Publication Number Publication Date
JP2008506357A JP2008506357A (ja) 2008-03-06
JP2008506357A5 true JP2008506357A5 (https=) 2011-02-03
JP5060284B2 JP5060284B2 (ja) 2012-10-31

Family

ID=34896141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007505491A Expired - Fee Related JP5060284B2 (ja) 2004-03-30 2005-03-30 ウイルスタンパク質の免疫抑制作用のモデュレーションに関与するポリペプチド配列

Country Status (14)

Country Link
US (2) US8178657B2 (https=)
EP (1) EP1732585B1 (https=)
JP (1) JP5060284B2 (https=)
CN (1) CN1961001B (https=)
AT (1) ATE472334T1 (https=)
AU (1) AU2005229411B2 (https=)
BR (1) BRPI0509497B1 (https=)
CA (1) CA2561376C (https=)
DE (1) DE602005022056D1 (https=)
ES (1) ES2347445T3 (https=)
IL (1) IL178205A (https=)
MX (1) MXPA06011272A (https=)
WO (1) WO2005095442A1 (https=)
ZA (1) ZA200608178B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9777044B2 (en) 2003-05-02 2017-10-03 Centre National De La Recherche Scientifique (Cnrs) GLUT-1 as a receptor for HTLV envelopes and its uses
DK1871391T3 (da) 2005-03-30 2012-04-16 Viroxis Endogen retrovirus og proteiner, der kodes af env som target for cancerbehandling
US20070185025A1 (en) * 2005-09-11 2007-08-09 The Trustees Of Columbia University In The City Of New York Filoviral immunosuppressive peptides and uses thereof
US20080299150A1 (en) * 2007-05-08 2008-12-04 Sankhia Corporation Method and system for processing immuno-competent cells in view of an antiviral therapy, and related therapeutic process
US8323891B2 (en) * 2008-08-01 2012-12-04 Claflin University miRNA triplex formations for the downregulation of viral replication
RU2008140688A (ru) * 2008-10-15 2010-04-20 Михаил Аркадьевич Шурдов (RU) Иммуносупрессивный пептид
JP5624994B2 (ja) 2009-01-09 2014-11-12 サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィク 新たなレセプター結合性リガンド、生物学的対象の細胞の検出におけるその使用
WO2011092199A1 (en) * 2010-01-26 2011-08-04 Institut Gustave Roussy Mutated xmrv env proteins in the immunosuppressive domain
US20130197612A1 (en) 2010-02-26 2013-08-01 Jack W. Lasersohn Electromagnetic Radiation Therapy
US20130260394A1 (en) * 2010-09-17 2013-10-03 Centre National De La Recherche Scientifique Method for the diagnosis and/or prognosis of inflammatory states
US8895027B2 (en) * 2011-07-20 2014-11-25 Merial Limited Recombinant feline leukemia virus vaccine containing optimized feline leukemia virus envelope gene
US9636396B2 (en) 2011-12-07 2017-05-02 Centre National De La Recherche Scientifique Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties
CA2856180C (en) 2011-12-07 2022-09-06 Viroxis S.A.S. Mutated lentiviral env proteins and their use as drugs
EP3004143B1 (en) 2013-06-07 2019-10-23 Viroxis S.A.S. Mutated non-primate lentiviral env proteins and their use as drugs
EP3309178A4 (en) * 2015-06-11 2019-05-08 Keio University FUSION PROTEIN OR CONJUGATED PROTEIN, CARRIER FOR INTRA-CELLULAR DELIVERY, PARTICLE PEPTIDE, CELL MEMBRANE PERMEATION AMPLIFIER, DNA AND VECTOR
JP7037486B2 (ja) * 2015-10-01 2022-03-16 エイムヴィオン・アクティエセルスカブ 医薬としてのヒト由来免疫抑制タンパク質およびペプチドの使用
DK3676285T3 (da) 2017-09-01 2026-01-19 Inprother Aps Vaccine til anvendelse i profylakse og/eller behandling af en sygdom
AU2019343045A1 (en) 2018-09-18 2021-05-13 Vnv Newco Inc. ARC-based capsids and uses thereof
US11129892B1 (en) 2020-05-18 2021-09-28 Vnv Newco Inc. Vaccine compositions comprising endogenous Gag polypeptides
CA3204201A1 (en) 2021-01-13 2022-07-21 Thierry Heidmann Measles-hiv or measles-htlv vaccine
WO2024218400A1 (en) 2023-04-21 2024-10-24 Inprother Aps Improved expression of surface-displayed antigens

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822606A (en) 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
ES2179854T3 (es) 1988-12-13 2003-02-01 Harvard College Materiales aislados de felv prototipos para uso en modelos de enfermedades y vacunas.
FR2771011B1 (fr) * 1997-11-17 2000-01-28 Hippocampe Obtention de vaccins destines a prevenir les effets pathogenes associes a une infection retrovirale
FR2780069B1 (fr) * 1998-06-23 2002-06-28 Inst Nat Sante Rech Med Famille de sequences nucleiques et de sequences proteiques deduites presentant des motifs retroviraux endogenes humains et leurs applications
JP2003512844A (ja) * 1999-10-28 2003-04-08 ユニヴェルシテ・ドゥ・ジュネーブ 多発性硬化症関連スーパー抗原
AU2002230758A1 (en) * 2000-12-11 2002-06-24 Tufts University Treatment and prevention of EBV infection and EBV-associated disorders
GB0112126D0 (en) 2001-05-18 2001-07-11 Allergene Inc Composition

Similar Documents

Publication Publication Date Title
JP2008506357A5 (https=)
US20250327065A1 (en) Disulfide-rich peptide libraries and methods of use thereof
Chappell et al. Expression levels of MHC class I molecules are inversely correlated with promiscuity of peptide binding
García-Martín et al. ChemMatrix, a poly (ethylene glycol)-based support for the solid-phase synthesis of complex peptides
Dietrich et al. Peptides as drugs: from screening to application
JP7274228B2 (ja) 病気の治療のためのポリペプチド
JP6047231B2 (ja) β−ヘアピンペプチド模倣薬
JP2018171063A5 (https=)
JP2011523550A5 (https=)
CN115246874B (zh) 一种重组新型冠状病毒s-rbd三聚体蛋白、其制备方法和应用
JP2023504914A5 (https=)
JP2019506839A5 (https=)
JP7604368B2 (ja) ストレス症候群、免疫反応症候群及び卒中症候群の処置のためのポリペプチド
USRE44747E1 (en) Mapping and reconstitution of a conformational discontinuous binding surface
Hirsch et al. Identification of a new subgroup of SIVagm in tantalus monkeys
Iglesias et al. Structural information in therapeutic peptides: emerging applications in biomedicine
CN100577686C (zh) 寡聚肽及其治疗hiv感染的用途
CN112543765A (zh) 能够刺激细胞因子释放的新型肽及其衍生物
JP2009062372A (ja) 高分子質量レクチンの生産
JP2024539609A5 (https=)
JP2023541764A5 (https=)
JP2019525764A5 (https=)
JP2018533974A5 (https=)
CN106866795B (zh) 一种狂犬病毒抑制多肽及其制备方法和应用
WO2021015237A1 (ja) 抗体酵素の革新的製造技術